(Q112052444)

1

Caterina Prelli Bozzo

0 references

Christine Goffinet

23

Christine Goffinet

0 references

Daniel Sauter

21

Daniel Sauter

0 references

Frank Kirchhoff

32

Frank Kirchhoff

0 references

Sandra Heller

7

Sandra Heller

0 references

Alexander Kleger

30

Alexander Kleger

0 references

Lennart Koepke

4

Lennart Koepke

0 references

Dorota Kmiec

9

Dorota Kmiec

0 references

Meta Volcic

3

Meta Volcic

0 references

Carina Conzelmann

10

Carina Conzelmann

0 references

Fabian Zech

12

Fabian Zech

0 references

Lukas Wettstein

15

Lukas Wettstein

0 references

Tatjana Weil

16

Tatjana Weil

0 references

Desiree Schütz

6

Desiree Schütz

0 references

Jana Krüger

5

Jana Krüger

0 references

author name string

Christina M Stürzel

8

0 references

Janis Müller

11

0 references

Elisabeth Braun

13

0 references

Rüdiger Groß

14

0 references

Johanna Weiß

17

0 references

Federica Diofano

18

0 references

Armando A Rodríguez Alfonso

19

0 references

Sebastian Wiese

20

0 references

Jan Münch

22

0 references

Alberto Catanese

24

0 references

Michael Schön

25

0 references

Tobias M Boeckers

26

0 references

Steffen Stenger

27

0 references

Kei Sato

28

0 references

Steffen Just

29

0 references

Konstantin M J Sparrer

describes a project that uses

31

0 references

language of work or name

English

0 references

publication date

28 July 2021

0 references

published in

Nature Communications

0 references

volume

12

0 references

issue

1

0 references

page(s)

4584

0 references

ImageJ

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC8319209/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

SARS-CoV-2 productively infects human gut enterocytes

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Vpu modulates DNA repair to suppress innate sensing and hyper-integration of HIV-1

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Syncytia formation by SARS-CoV-2 infected cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Peptide and peptide-based inhibitors of SARS-CoV-2 entry

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Drug inhibition of SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Cardiovascular Manifestations of COVID-19 Infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

DNA damage tolerance pathway involving DNA polymerase ι and the tumor suppressor p53 regulates DNA replication fork progression

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Opposing activities of IFITM proteins in SARS-CoV-2 infection

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Interferon induction of IFITM proteins promotes infection by human coronavirus OC43

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITMs restrict the replication of multiple pathogenic viruses

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Remdesivir but not famotidine inhibits SARS-CoV-2 replication in human pluripotent stem cell-derived intestinal organoids

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

The broad-spectrum antiviral functions of IFIT and IFITM proteins

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM proteins-cellular inhibitors of viral entry.

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM proteins restrict viral membrane hemifusion

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

A novel coronavirus associated with severe acute respiratory syndrome

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM3 requires an amphipathic helix for antiviral activity.

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Identification of residues controlling restriction versus enhancing activities of IFITM proteins on the entry of human coronaviruses

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Cell entry mechanisms of SARS-CoV-2

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

An improved method for high-throughput quantification of autophagy in mammalian cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Interplay between SARS-CoV-2 and the type I interferon response

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Antiviral Protection by IFITM3 In Vivo

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Calcium activated potassium channel expression during human iPS cell-derived neurogenesis.

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

The IFITM protein family in adaptive immunity

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Cardiovascular complications in COVID-19

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Retinoic acid worsens ATG10-dependent autophagy impairment in TBK1-mutant hiPSC-derived motoneurons through SQSTM1/p62 accumulation

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

SARS-CoV-2 targets neurons of 3D human brain organoids

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Evolutionary conflicts and adverse effects of antiviral factors

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Interferon-Induced Transmembrane Protein 3 Blocks Fusion of Diverse Enveloped Viruses by Altering Mechanical Properties of Cell Membranes

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y

Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019

17 May 2022

1 reference

https://api.crossref.org/works/10.1038/S41467-021-24817-Y